NM_012203.2:c.83+52delG
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_012203.2(GRHPR):c.83+52delG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.173 in 1,363,358 control chromosomes in the GnomAD database, including 21,753 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.15 ( 1901 hom., cov: 29)
Exomes 𝑓: 0.18 ( 19852 hom. )
Consequence
GRHPR
NM_012203.2 intron
NM_012203.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.433
Publications
2 publications found
Genes affected
GRHPR (HGNC:4570): (glyoxylate and hydroxypyruvate reductase) This gene encodes an enzyme with hydroxypyruvate reductase, glyoxylate reductase, and D-glycerate dehydrogenase enzymatic activities. The enzyme has widespread tissue expression and has a role in metabolism. Type II hyperoxaluria is caused by mutations in this gene. [provided by RefSeq, Jul 2008]
GRHPR Gene-Disease associations (from GenCC):
- primary hyperoxaluria type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 9-37422883-CG-C is Benign according to our data. Variant chr9-37422883-CG-C is described in ClinVar as Benign. ClinVar VariationId is 204218.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.183 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GRHPR | NM_012203.2 | c.83+52delG | intron_variant | Intron 1 of 8 | ENST00000318158.11 | NP_036335.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.149 AC: 22613AN: 152074Hom.: 1899 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
22613
AN:
152074
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.166 AC: 24285AN: 146674 AF XY: 0.165 show subpopulations
GnomAD2 exomes
AF:
AC:
24285
AN:
146674
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.176 AC: 213228AN: 1211166Hom.: 19852 Cov.: 12 AF XY: 0.175 AC XY: 105998AN XY: 604794 show subpopulations
GnomAD4 exome
AF:
AC:
213228
AN:
1211166
Hom.:
Cov.:
12
AF XY:
AC XY:
105998
AN XY:
604794
show subpopulations
African (AFR)
AF:
AC:
1993
AN:
27706
American (AMR)
AF:
AC:
6586
AN:
35042
Ashkenazi Jewish (ASJ)
AF:
AC:
5812
AN:
23588
East Asian (EAS)
AF:
AC:
1059
AN:
34860
South Asian (SAS)
AF:
AC:
9862
AN:
75470
European-Finnish (FIN)
AF:
AC:
7472
AN:
46928
Middle Eastern (MID)
AF:
AC:
897
AN:
3704
European-Non Finnish (NFE)
AF:
AC:
170613
AN:
912376
Other (OTH)
AF:
AC:
8934
AN:
51492
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
8675
17351
26026
34702
43377
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5588
11176
16764
22352
27940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.149 AC: 22617AN: 152192Hom.: 1901 Cov.: 29 AF XY: 0.148 AC XY: 10991AN XY: 74396 show subpopulations
GnomAD4 genome
AF:
AC:
22617
AN:
152192
Hom.:
Cov.:
29
AF XY:
AC XY:
10991
AN XY:
74396
show subpopulations
African (AFR)
AF:
AC:
3128
AN:
41540
American (AMR)
AF:
AC:
2793
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
874
AN:
3470
East Asian (EAS)
AF:
AC:
221
AN:
5168
South Asian (SAS)
AF:
AC:
623
AN:
4820
European-Finnish (FIN)
AF:
AC:
1669
AN:
10594
Middle Eastern (MID)
AF:
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12646
AN:
67990
Other (OTH)
AF:
AC:
360
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
971
1942
2912
3883
4854
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
250
500
750
1000
1250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
337
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Primary hyperoxaluria, type II Uncertain:1Benign:1
Jan 23, 2024
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 27, 2014
Clinical Biochemistry Laboratory, Health Services Laboratory
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.